BackImmunovia AB Overview

Immunovia AB Current Cash

Latest current cash for IMMVF: $35M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$34.90M
↑ 19.24% YoYΔ $5.63M vs prior year quarter

Peer trimmed avg / median

Loading

Immunovia AB Current Cash History

Loading

Immunovia AB vs. peers: Current Cash Comparison

Loading

Immunovia AB Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Immunovia AB (IMMVF) FAQ

As of the most recent data (June 2026), IMMVF shows a current cash of $35M. That compares with $29M in the prior-year period — up 19.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IMMVF's current cash is now $35M (was $29M) — a 19.2% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Immunovia AB is outperforming or lagging.

Tracking IMMVF's current cash over time shows whether Immunovia AB is scaling, shrinking, or reshaping that part of the business. The current reading is $35M That compares with $29M in the prior-year period — up 19.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Immunovia AB's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $35M) with ownership activity and broader fundamentals.